Anand Krishnan

8PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Peripheral nervous systemRegenerative medicine (incl. stem cells)Molecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 01, 2026
Macrophage migration inhibitory factor is a potential therapeutic target for cisplatin induced peripheral neuropathy in breast cancer.

|Jul 08, 2025
Defining the cellular and molecular features of nerve-invaded cancer cells using a newly characterized experimental model.

Nickson Joseph, Sanskriti Shrestha, Ivanka Sassmannshausen

|Jul 07, 2025
Schwann cells modified to secrete MANF is a potential cellular therapy for peripheral nerve regeneration.

Bhadrapriya Sivakumar, Caleb Hammond, Valeria Martinez

|Apr 29, 2025
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.

Prachi Walke, Jared D W Price, Frederick S Vizeacoumar

|Apr 13, 2023
Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF): An Emerging Therapeutic Target for Neurodegenerative Disorders.

Bhadrapriya Sivakumar, Anand Krishnan

|Nov 24, 2022
Survival of compromised adult sensory neurons involves macrovesicular formation.

Anand Krishnan, Aparna Areti, Prashanth Komirishetty

Pageof 2

Frequent Collaborators

2 joint publications

Frederick S Vizeacoumar

2 joint publications

Franco J Vizeacoumar

1 joint publications

Vincent Maranda

1 joint publications

Douglas W Zochodne